These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22911397

  • 1. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer.
    Pedroza-Gonzalez A, Verhoef C, Ijzermans JN, Peppelenbosch MP, Kwekkeboom J, Verheij J, Janssen HL, Sprengers D.
    Hepatology; 2013 Jan; 57(1):183-94. PubMed ID: 22911397
    [Abstract] [Full Text] [Related]

  • 2. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [Abstract] [Full Text] [Related]

  • 3. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [Abstract] [Full Text] [Related]

  • 4. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    van Beek AA, Zhou G, Doukas M, Boor PPC, Noordam L, Mancham S, Campos Carrascosa L, van der Heide-Mulder M, Polak WG, Ijzermans JNM, Pan Q, Heirman C, Mahne A, Bucktrout SL, Bruno MJ, Sprengers D, Kwekkeboom J.
    Int J Cancer; 2019 Aug 15; 145(4):1111-1124. PubMed ID: 30719701
    [Abstract] [Full Text] [Related]

  • 5. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X, Li B, Ye H, Long D.
    Arch Immunol Ther Exp (Warsz); 2011 Aug 15; 59(4):309-14. PubMed ID: 21633918
    [Abstract] [Full Text] [Related]

  • 6. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F.
    Cancer Res; 2005 Mar 15; 65(6):2457-64. PubMed ID: 15781662
    [Abstract] [Full Text] [Related]

  • 7. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr 15; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 8. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y.
    J Hepatol; 2006 Aug 15; 45(2):254-62. PubMed ID: 16600416
    [Abstract] [Full Text] [Related]

  • 9. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
    Zhang HH, Mei MH, Fei R, Liao WJ, Wang XY, Qin LL, Wang JH, Wei L, Chen HS.
    Int J Oncol; 2010 Apr 15; 36(4):841-8. PubMed ID: 20198327
    [Abstract] [Full Text] [Related]

  • 10. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.
    Gastroenterology; 2007 Jun 15; 132(7):2328-39. PubMed ID: 17570208
    [Abstract] [Full Text] [Related]

  • 11. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X, Du Y, Huang Z.
    Immunol Lett; 2012 Jun 15; 148(1):83-9. PubMed ID: 23000301
    [Abstract] [Full Text] [Related]

  • 12. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang SG, Ma KS, Li XW, Dong JH.
    Hum Immunol; 2010 Dec 15; 71(12):1180-6. PubMed ID: 20870003
    [Abstract] [Full Text] [Related]

  • 13. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.
    J Clin Oncol; 2007 Jun 20; 25(18):2586-93. PubMed ID: 17577038
    [Abstract] [Full Text] [Related]

  • 14. Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.
    Nishikawa H, Kato T, Hirayama M, Orito Y, Sato E, Harada N, Gnjatic S, Old LJ, Shiku H.
    Cancer Res; 2008 Jul 15; 68(14):5948-54. PubMed ID: 18632650
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Cai XY, He HW, Jin JJ, Cheng YF, Fan J, Sun J, Qiu SJ.
    J Gastroenterol Hepatol; 2013 Sep 15; 28(9):1555-64. PubMed ID: 23517245
    [Abstract] [Full Text] [Related]

  • 16. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, Bocci EB, Nocentini G, Gerli R, Riccardi C.
    Eur J Immunol; 2011 Aug 15; 41(8):2269-78. PubMed ID: 21557210
    [Abstract] [Full Text] [Related]

  • 17. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
    Wang F, Jing X, Li G, Wang T, Yang B, Zhu Z, Gao Y, Zhang Q, Yang Y, Wang Y, Wang P, Du Z.
    Liver Int; 2012 Apr 15; 32(4):644-55. PubMed ID: 22118340
    [Abstract] [Full Text] [Related]

  • 18. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH, Fei R, Mei MH, Liao WJ, Wang XY, Cong X, Qin LL, Ji Y, Wang SX, Wei L, Chen HS.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr 15; 15(4):266-72. PubMed ID: 17456313
    [Abstract] [Full Text] [Related]

  • 19. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
    Kim YH, Shin SM, Choi BK, Oh HS, Kim CH, Lee SJ, Kim KH, Lee DG, Park SH, Kwon BS.
    J Immunol; 2015 Nov 15; 195(10):4721-9. PubMed ID: 26423152
    [Abstract] [Full Text] [Related]

  • 20. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM, Kapadia MJ, Alexander J, Kernochan LE, Swanson PE, Yeh MM.
    Am J Surg Pathol; 2012 Jul 15; 36(7):980-6. PubMed ID: 22446942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.